References
- Thomas P, Alexander PE, Ahmed U, et al. Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review. J Matern Fetal Neonatal Med. 2020:1–8.DOI:https://doi.org/10.1080/14767058.2020.1786055
- Shanes ED, Mithal LB, Otero S, et al. Placental pathology in CoVID-19. Am J Clin Pathol. 2020;154(1):23–32.
- Ng WF, Wong SF, Lam A, et al. The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology. 2006;38(3):210–218.
- Baud D, Greub G, Favre G, et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection. JAMA. 2020;323(21):2198–2200.
- Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–224.
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.
- Chadchan SB, Maurya VK, Popli P, et al. The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human 1 endometrial stromal cell decidualization. bioRxiv. 2020.
- Li M, Chen L, Zhang J, et al. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One. 2020;15(4):e0230295.
- Zheng Q, Duan T, Jin L. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal fetal interface. Reprod Dev Med. 2020;4(1):7–1.
- Pique-Regi R, Romero R, Tarca AL, et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? eLife. 2020;9:e58716.